Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux

Fig. 1

Kaplan-Meier survival analysis of glioma patients based on ATG4C mRNA expression levels. a Comparison of overall survival (OS) profiles between patients with ATG4C high and low expression levels in 975 glioma patients. b Comparison of overall survival (OS) profiles between patients with ATG4C high and low expression levels in 414 LGG patients. c Comparison of relapse free survival (RFS) time between patients with ATG4C high and low expression levels in 414 LGG patients. d Comparison of ATG4C mRNA expression between 16 glioblastoma tissues and 9 normal brain tissues. e Comparison of the mRNA expression of ATG4C in patients with different pathological grades of gliomas

Back to article page